13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001964437-24-000011
Total Value
$279.8M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | ASND | 200,285 | $29.9M | 10.69% |
| 2 | DISC MEDICINE INC | IRON | 511,041 | $25.1M | 8.98% |
| 3 | VAXCYTE INC | PCVX | 204,987 | $23.4M | 8.37% |
| 4 | CG ONCOLOGY INC | CGON | 520,119 | $19.6M | 7.01% |
| 5 | COGENT BIOSCIENCES INC | COGT | 1,712,899 | $18.5M | 6.61% |
| 6 | CARGO THERAPEUTICS INC | 14179K101 | 1,002,461 | $18.5M | 6.61% |
| 7 | CYTOKINETICS INC | CYTK | 331,283 | $17.5M | 6.25% |
| 8 | PHATHOM PHARMACEUTICALS INC | PHAT | 874,590 | $15.8M | 5.65% |
| 9 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 298,974 | $15.1M | 5.39% |
| 10 | CELCUITY INC | CELC | 946,335 | $14.1M | 5.04% |
| 11 | ARGENX SE | ARGX | 22,111 | $12.0M | 4.28% |
| 12 | SYNDAX PHARMACEUTICALS INC | SNDX | 501,978 | $9.7M | 3.45% |
| 13 | SILENCE THERAPEUTICS PLC | SLNCF | 481,127 | $8.7M | 3.13% |
| 14 | ABIVAX SA | AAVXF | 648,019 | $7.5M | 2.67% |
| 15 | INOZYME PHARMA INC | 45790W108 | 1,368,810 | $7.2M | 2.56% |
| 16 | MERUS N V | N5749R100 | 131,240 | $6.6M | 2.34% |
| 17 | KALVISTA PHARMACEUTICALS INC | KALV | 556,489 | $6.4M | 2.30% |
| 18 | NEUMORA THERAPEUTICS INC. | NMRA | 432,996 | $5.7M | 2.04% |
| 19 | CRINETICS PHARMACEUTICALS IN | CRNX | 109,567 | $5.6M | 2.00% |
| 20 | IRONWOOD PHARMACEUTICALS INC | IRWD | 1,120,409 | $4.6M | 1.65% |
| 21 | BIOMARIN PHARMACEUTICAL INC | BMRN | 37,432 | $2.6M | 0.94% |
| 22 | ITEOS THERAPEUTICS INC | 46565G104 | 195,704 | $2.0M | 0.71% |
| 23 | CONTINEUM THERAPEUTICS INC | CTNM | 77,297 | $1.5M | 0.53% |
| 24 | ARRIVENT BIOPHARMA INC | AVBP | 47,266 | $1.1M | 0.40% |
| 25 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 31,529 | $1.1M | 0.38% |